[Form 4] Wells Fargo & Co. Insider Trading Activity
Structure Therapeutics Inc. (GPCR) � Form 4 filing dated 07/03/2025
Chief Executive Officer and Director Raymond C. Stevens reported several equity transactions in the company’s ordinary shares and American Depositary Shares (ADSs).
- 03/01/2025 � Tax withholding: 12,495 ordinary shares (Code F) were automatically withheld at an average price of $7.9166 to satisfy tax obligations linked to a prior restricted-share-unit (RSU) vesting.
- 07/01/2025 � Performance share vesting: 89,697 ordinary shares (Code A) were credited at $0 after performance criteria on March 2024 PSUs were partially met. On the same day, 16,050 shares were withheld for taxes (Code F, $6.8366).
- 05/21/2025 � Voluntary purchase: Stevens bought 1,000 ADSs (3,000 ordinary-share equivalent) through the company’s Employee Share Purchase Plan (Code A).
Post-transaction ownership
- Direct: 1,194,830 ordinary shares and 1,000 ADSs.
- Indirect (family trust): 1,554,586 ordinary shares and 4,000 ADSs.
The filing indicates continued equity accumulation by the CEO, with the majority of new shares originating from performance-based awards. Disposals were administrative (tax withholding) rather than discretionary sales, limiting negative interpretation.
Structure Therapeutics Inc. (GPCR) � Comunicazione Form 4 datata 03/07/2025
Il CEO e Direttore Raymond C. Stevens ha segnalato diverse operazioni su azioni ordinarie e American Depositary Shares (ADS) della società.
- 01/03/2025 � Ritenuta fiscale: 12.495 azioni ordinarie (Codice F) sono state trattenute automaticamente a un prezzo medio di $7,9166 per adempiere agli obblighi fiscali relativi al consolidamento di Restricted Share Units (RSU) precedenti.
- 01/07/2025 � Consolidamento azioni di performance: 89.697 azioni ordinarie (Codice A) sono state assegnate a $0 dopo il parziale raggiungimento dei criteri di performance sui PSU di marzo 2024. Nello stesso giorno, 16.050 azioni sono state trattenute per tasse (Codice F, $6,8366).
- 21/05/2025 � Acquisto volontario: Stevens ha acquistato 1.000 ADS (equivalenti a 3.000 azioni ordinarie) tramite il Piano di Acquisto Azionario per Dipendenti (Codice A).
Possesso azionario post-transazione
- Diretto: 1.194.830 azioni ordinarie e 1.000 ADS.
- Indiretto (fondo familiare): 1.554.586 azioni ordinarie e 4.000 ADS.
La comunicazione evidenzia un continuo accumulo di azioni da parte del CEO, con la maggior parte delle nuove azioni derivanti da premi basati sulle performance. Le cessioni sono state di natura amministrativa (ritenute fiscali) e non vendite discrezionali, limitando interpretazioni negative.
Structure Therapeutics Inc. (GPCR) � Presentación Formulario 4 fechada el 03/07/2025
El Director Ejecutivo y miembro del consejo, Raymond C. Stevens, reportó varias transacciones de acciones ordinarias y American Depositary Shares (ADS) de la compañía.
- 01/03/2025 � Retención fiscal: 12,495 acciones ordinarias (Código F) fueron retenidas automáticamente a un precio promedio de $7.9166 para cumplir con obligaciones fiscales relacionadas con la consolidación de Restricted Share Units (RSU) previas.
- 01/07/2025 � Consolidación de acciones por desempeño: 89,697 acciones ordinarias (Código A) se acreditaron a $0 tras cumplir parcialmente con los criterios de desempeño de los PSU de marzo 2024. Ese mismo día, se retuvieron 16,050 acciones para impuestos (Código F, $6.8366).
- 21/05/2025 � Compra voluntaria: Stevens adquirió 1,000 ADS (equivalentes a 3,000 acciones ordinarias) mediante el Plan de Compra de Acciones para Empleados (Código A).
Propiedad tras la transacción
- Directa: 1,194,830 acciones ordinarias y 1,000 ADS.
- Indirecta (fideicomiso familiar): 1,554,586 acciones ordinarias y 4,000 ADS.
El reporte indica una acumulación continua de acciones por parte del CEO, con la mayoría de las nuevas acciones provenientes de premios basados en desempeño. Las disposiciones fueron administrativas (retención fiscal) y no ventas discrecionales, lo que limita interpretaciones negativas.
Structure Therapeutics Inc. (GPCR) � 2025� 7� 3일자 Form 4 제출
최고경영자이� 이사� Raymond C. Stevens가 회사� 보통� � 미국예탁증서(ADS)� 관� 여러 주식 거래� 보고했습니다.
- 2025� 3� 1� � 세금 원천징수: 이전 제한 주식 단위(RSU) 취득� 관련된 세금 의무� 충족하기 위해 평균 가� $7.9166� 12,495� 보통�(Code F)가 자동으로 원천징수되었습니�.
- 2025� 7� 1� � 성과 주식 취득: 2024� 3� PSU� 성과 기준 일부 달성� 따라 89,697� 보통�(Code A)가 $0� 입금되었습니�. 같은 � 세금 납부� 위해 16,050주가 원천징수되었습니�(Code F, $6.8366).
- 2025� 5� 21� � 자발� 구매: Stevens� 직원 주식 구매 계획� 통해 1,000 ADS(보통� 3,000� 상당)� 구매했습니다(Code A).
거래 � 보유 현황
- 직접 보유: 1,194,830� 보통� � 1,000 ADS.
- 간접 보유(가� 신탁): 1,554,586� 보통� � 4,000 ADS.
제출 서류� CEO� 지속적� 주식 축적� 보여주며, 신규 주식 대부분은 성과 기반 보상에서 기인합니�. 처분은 관� 차원� 세금 원천징수였으며 임의 매도� 아니어서 부정적 해석� 제한합니�.
Structure Therapeutics Inc. (GPCR) � Dépôt du Formulaire 4 daté du 03/07/2025
Le Directeur Général et Administrateur Raymond C. Stevens a déclaré plusieurs transactions sur les actions ordinaires et les American Depositary Shares (ADS) de la société.
- 01/03/2025 � Retenue fiscale : 12 495 actions ordinaires (Code F) ont été automatiquement retenues à un prix moyen de 7,9166 $ pour satisfaire aux obligations fiscales liées à l’acquisition antérieure d’unités d’actions restreintes (RSU).
- 01/07/2025 � Acquisition d’actions de performance : 89 697 actions ordinaires (Code A) ont été créditées à 0 $ après que les critères de performance des PSU de mars 2024 ont été partiellement remplis. Le même jour, 16 050 actions ont été retenues pour impôts (Code F, 6,8366 $).
- 21/05/2025 � Achat volontaire : Stevens a acheté 1 000 ADS (équivalent à 3 000 actions ordinaires) via le Plan d’Achat d’Actions des Employés (Code A).
Possession après transaction
- Directe : 1 194 830 actions ordinaires et 1 000 ADS.
- Indirecte (trust familial) : 1 554 586 actions ordinaires et 4 000 ADS.
Le dépôt indique une accumulation continue d’actions par le PDG, la majorité des nouvelles actions provenant de récompenses basées sur la performance. Les cessions étaient de nature administrative (retenue fiscale) et non des ventes discrétionnaires, limitant ainsi les interprétations négatives.
Structure Therapeutics Inc. (GPCR) � Form 4 Einreichung vom 03.07.2025
Chief Executive Officer und Direktor Raymond C. Stevens meldete mehrere Aktiengeschäfte mit den Stammaktien und American Depositary Shares (ADS) des Unternehmens.
- 01.03.2025 � Steuerabzug: 12.495 Stammaktien (Code F) wurden automatisch zu einem Durchschnittspreis von $7,9166 einbehalten, um Steuerverpflichtungen im Zusammenhang mit der Ausübung von Restricted Share Units (RSU) zu erfüllen.
- 01.07.2025 � Performance-Aktiensperrung: 89.697 Stammaktien (Code A) wurden zu $0 gutgeschrieben, nachdem die Leistungsziele der PSU vom März 2024 teilweise erfüllt wurden. Am selben Tag wurden 16.050 Aktien für Steuern einbehalten (Code F, $6,8366).
- 21.05.2025 � Freiwilliger Kauf: Stevens erwarb 1.000 ADS (entspricht 3.000 Stammaktien) über den Mitarbeiteraktienkaufplan (Code A).
Eigentumsverhältnisse nach der Transaktion
- Direkt: 1.194.830 Stammaktien und 1.000 ADS.
- Indirekt (Familientrust): 1.554.586 Stammaktien und 4.000 ADS.
Die Einreichung zeigt eine fortgesetzte Aktienakkumulation durch den CEO, wobei der Großteil der neuen Aktien aus leistungsabhängigen Vergütungen stammt. Veräußerungen waren administrativer Natur (Steuerabzug) und keine freiwilligen Verkäufe, was negative Interpretationen einschränkt.
- CEO purchased 1,000 ADSs through the Employee Share Purchase Plan, indicating personal cash commitment to GPCR shares.
- Performance milestones achieved, triggering 89,697-share PSU vesting, which may signal that internal operational targets were met.
- None.
Insights
TL;DR: Primarily administrative insider activity; small open-market purchase suggests modest confidence, overall impact neutral.
The bulk of share movements stem from PSU vesting and mandatory tax withholding, which do not reflect market sentiment. The voluntary acquisition of 1,000 ADSs under the ESPP is positive but immaterial versus Stevens� 2.7 million-share (direct+indirect, ordinary-share equivalent) stake. No open-market selling occurred, and performance hurdles being met may imply operational targets were achieved, yet this is already compensated via equity. As such, I view the filing as neutral for valuation; it neither signals significant insider buying pressure nor raises liquidity-driven concerns.
TL;DR: Performance PSU vesting confirms goal attainment; governance posture unchanged; investor signal modestly constructive.
Issuance of 89,697 shares reflects board-approved incentive alignment—half vests now, remainder on 01/01/2027, reinforcing long-term retention. Tax-cover sales are routine and should not be viewed negatively. The ESPP purchase, while small, demonstrates alignment with minority shareholders. No red flags on reporting timeliness or footnote clarity. Overall governance implications are benign to slightly positive.
Structure Therapeutics Inc. (GPCR) � Comunicazione Form 4 datata 03/07/2025
Il CEO e Direttore Raymond C. Stevens ha segnalato diverse operazioni su azioni ordinarie e American Depositary Shares (ADS) della società.
- 01/03/2025 � Ritenuta fiscale: 12.495 azioni ordinarie (Codice F) sono state trattenute automaticamente a un prezzo medio di $7,9166 per adempiere agli obblighi fiscali relativi al consolidamento di Restricted Share Units (RSU) precedenti.
- 01/07/2025 � Consolidamento azioni di performance: 89.697 azioni ordinarie (Codice A) sono state assegnate a $0 dopo il parziale raggiungimento dei criteri di performance sui PSU di marzo 2024. Nello stesso giorno, 16.050 azioni sono state trattenute per tasse (Codice F, $6,8366).
- 21/05/2025 � Acquisto volontario: Stevens ha acquistato 1.000 ADS (equivalenti a 3.000 azioni ordinarie) tramite il Piano di Acquisto Azionario per Dipendenti (Codice A).
Possesso azionario post-transazione
- Diretto: 1.194.830 azioni ordinarie e 1.000 ADS.
- Indiretto (fondo familiare): 1.554.586 azioni ordinarie e 4.000 ADS.
La comunicazione evidenzia un continuo accumulo di azioni da parte del CEO, con la maggior parte delle nuove azioni derivanti da premi basati sulle performance. Le cessioni sono state di natura amministrativa (ritenute fiscali) e non vendite discrezionali, limitando interpretazioni negative.
Structure Therapeutics Inc. (GPCR) � Presentación Formulario 4 fechada el 03/07/2025
El Director Ejecutivo y miembro del consejo, Raymond C. Stevens, reportó varias transacciones de acciones ordinarias y American Depositary Shares (ADS) de la compañía.
- 01/03/2025 � Retención fiscal: 12,495 acciones ordinarias (Código F) fueron retenidas automáticamente a un precio promedio de $7.9166 para cumplir con obligaciones fiscales relacionadas con la consolidación de Restricted Share Units (RSU) previas.
- 01/07/2025 � Consolidación de acciones por desempeño: 89,697 acciones ordinarias (Código A) se acreditaron a $0 tras cumplir parcialmente con los criterios de desempeño de los PSU de marzo 2024. Ese mismo día, se retuvieron 16,050 acciones para impuestos (Código F, $6.8366).
- 21/05/2025 � Compra voluntaria: Stevens adquirió 1,000 ADS (equivalentes a 3,000 acciones ordinarias) mediante el Plan de Compra de Acciones para Empleados (Código A).
Propiedad tras la transacción
- Directa: 1,194,830 acciones ordinarias y 1,000 ADS.
- Indirecta (fideicomiso familiar): 1,554,586 acciones ordinarias y 4,000 ADS.
El reporte indica una acumulación continua de acciones por parte del CEO, con la mayoría de las nuevas acciones provenientes de premios basados en desempeño. Las disposiciones fueron administrativas (retención fiscal) y no ventas discrecionales, lo que limita interpretaciones negativas.
Structure Therapeutics Inc. (GPCR) � 2025� 7� 3일자 Form 4 제출
최고경영자이� 이사� Raymond C. Stevens가 회사� 보통� � 미국예탁증서(ADS)� 관� 여러 주식 거래� 보고했습니다.
- 2025� 3� 1� � 세금 원천징수: 이전 제한 주식 단위(RSU) 취득� 관련된 세금 의무� 충족하기 위해 평균 가� $7.9166� 12,495� 보통�(Code F)가 자동으로 원천징수되었습니�.
- 2025� 7� 1� � 성과 주식 취득: 2024� 3� PSU� 성과 기준 일부 달성� 따라 89,697� 보통�(Code A)가 $0� 입금되었습니�. 같은 � 세금 납부� 위해 16,050주가 원천징수되었습니�(Code F, $6.8366).
- 2025� 5� 21� � 자발� 구매: Stevens� 직원 주식 구매 계획� 통해 1,000 ADS(보통� 3,000� 상당)� 구매했습니다(Code A).
거래 � 보유 현황
- 직접 보유: 1,194,830� 보통� � 1,000 ADS.
- 간접 보유(가� 신탁): 1,554,586� 보통� � 4,000 ADS.
제출 서류� CEO� 지속적� 주식 축적� 보여주며, 신규 주식 대부분은 성과 기반 보상에서 기인합니�. 처분은 관� 차원� 세금 원천징수였으며 임의 매도� 아니어서 부정적 해석� 제한합니�.
Structure Therapeutics Inc. (GPCR) � Dépôt du Formulaire 4 daté du 03/07/2025
Le Directeur Général et Administrateur Raymond C. Stevens a déclaré plusieurs transactions sur les actions ordinaires et les American Depositary Shares (ADS) de la société.
- 01/03/2025 � Retenue fiscale : 12 495 actions ordinaires (Code F) ont été automatiquement retenues à un prix moyen de 7,9166 $ pour satisfaire aux obligations fiscales liées à l’acquisition antérieure d’unités d’actions restreintes (RSU).
- 01/07/2025 � Acquisition d’actions de performance : 89 697 actions ordinaires (Code A) ont été créditées à 0 $ après que les critères de performance des PSU de mars 2024 ont été partiellement remplis. Le même jour, 16 050 actions ont été retenues pour impôts (Code F, 6,8366 $).
- 21/05/2025 � Achat volontaire : Stevens a acheté 1 000 ADS (équivalent à 3 000 actions ordinaires) via le Plan d’Achat d’Actions des Employés (Code A).
Possession après transaction
- Directe : 1 194 830 actions ordinaires et 1 000 ADS.
- Indirecte (trust familial) : 1 554 586 actions ordinaires et 4 000 ADS.
Le dépôt indique une accumulation continue d’actions par le PDG, la majorité des nouvelles actions provenant de récompenses basées sur la performance. Les cessions étaient de nature administrative (retenue fiscale) et non des ventes discrétionnaires, limitant ainsi les interprétations négatives.
Structure Therapeutics Inc. (GPCR) � Form 4 Einreichung vom 03.07.2025
Chief Executive Officer und Direktor Raymond C. Stevens meldete mehrere Aktiengeschäfte mit den Stammaktien und American Depositary Shares (ADS) des Unternehmens.
- 01.03.2025 � Steuerabzug: 12.495 Stammaktien (Code F) wurden automatisch zu einem Durchschnittspreis von $7,9166 einbehalten, um Steuerverpflichtungen im Zusammenhang mit der Ausübung von Restricted Share Units (RSU) zu erfüllen.
- 01.07.2025 � Performance-Aktiensperrung: 89.697 Stammaktien (Code A) wurden zu $0 gutgeschrieben, nachdem die Leistungsziele der PSU vom März 2024 teilweise erfüllt wurden. Am selben Tag wurden 16.050 Aktien für Steuern einbehalten (Code F, $6,8366).
- 21.05.2025 � Freiwilliger Kauf: Stevens erwarb 1.000 ADS (entspricht 3.000 Stammaktien) über den Mitarbeiteraktienkaufplan (Code A).
Eigentumsverhältnisse nach der Transaktion
- Direkt: 1.194.830 Stammaktien und 1.000 ADS.
- Indirekt (Familientrust): 1.554.586 Stammaktien und 4.000 ADS.
Die Einreichung zeigt eine fortgesetzte Aktienakkumulation durch den CEO, wobei der Großteil der neuen Aktien aus leistungsabhängigen Vergütungen stammt. Veräußerungen waren administrativer Natur (Steuerabzug) und keine freiwilligen Verkäufe, was negative Interpretationen einschränkt.